Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Activity for Diabetic Polyneuropathy

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Veza se sprema u međuspremnik
StatusVrbovanje
Sponzori
Virginia Commonwealth University
Suradnici
University of Kansas
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Utah

Ključne riječi

Sažetak

The proposed study will randomize participants with diabetic peripheral neuropathy into two groups. One group of participants will receive standard-of-care counseling while the other group will undergo supervised exercise and counseling to increase physical activity.

Opis

Type 2 diabetes (T2D) affects over 8% of Americans, and half will develop peripheral neuropathy, a progressive injury to the very longest nerves of the body. Our previous research has found that neuropathy can be detected early in its course and followed by examining nerves that reach to the skin using a small punch biopsy. These cutaneous nerves can be injured by high blood glucose, obesity and high triglycerides, but have the potential to regrow in response to treatments that improve these metabolic conditions. The proposed study will randomize participants with mild to moderate diabetic peripheral neuropathy to receive either generic annual counseling or an integrated program of moderate supervised exercise and actigraphy based anti sedentariness counseling.

Datumi

Posljednja provjera: 04/30/2020
Prvo podneseno: 01/08/2015
Predviđena prijava poslana: 01/12/2015
Prvo objavljeno: 01/18/2015
Posljednje ažuriranje poslano: 05/13/2020
Posljednje ažuriranje objavljeno: 05/17/2020
Stvarni datum početka studija: 10/31/2015
Procijenjeni datum primarnog završetka: 03/31/2022
Procijenjeni datum završetka studije: 03/31/2022

Stanje ili bolest

Diabetic Neuropathy

Intervencija / liječenje

Behavioral: Standard Care Counseling

Behavioral: Supervised Exercise and Counseling

Faza

-

Grupe ruku

RukaIntervencija / liječenje
Experimental: Standard Care Counseling
Participants randomized to the control group will receive diet and exercise counseling at baseline and 9 months. Participants will wear an ActivePAL for 7 days at baseline, 9 months, and 18 months without stimulation.
Behavioral: Standard Care Counseling
Experimental: Supervised Exercise and Counseling
Participants randomized to the intervention will perform supervised aerobic, resistance and balance training twice weekly for 12 weeks, and weekly thereafter. Actigraphy-based counseling to reduce sedentary behavior will follow a similar taper. Daily text messages, "tweets", emails, and social media posts at random times during waking hours will be used to provide reminders and motivational messages. Participants will have 11 separate 7-day continuous ActivePAL training session incorporating vibrostimulatory feedback spread across the treatment period.
Behavioral: Supervised Exercise and Counseling

Kriterij prihvatljivosti

Dobni uvjeti za studiranje 30 Years Do 30 Years
Spolovi koji ispunjavaju uvjete za studijAll
Prihvaća zdrave volontereDa
Kriteriji

Inclusion Criteria:

1. T2D defined by ADA criteria.

2. Peripheral neuropathy based on the Toronto Diabetic Neuropathy Expert Group consensus criteria for "Confirmed diabetic sensorimotor peripheral neuropathy".

3. Moderate DPN severity with a UENS of 2-18.

4. Age between 30 and 75.

5. Under the care of an identified Primary Care Physician (PCP).

Exclusion Criteria:

1. Any alternative cause for peripheral neuropathy. The following tests must have been found normal within the last 12 months or will be performed pre-randomization: vitamin B12, serum protein electrophoresis and immunofixation. ANA and TSH may be obtained if clinically indicated and not available from clinical records.

2. Family history of a non-diabetic neuropathy in a first-degree relative.

3. Severe or longstanding neuropathy: UENS > 18 or history of foot ulceration or amputation.

4. Participants taking Coumadin or oral factor X or thrombin inhibitor therapy will be considered on an individual basis by the site investigator.

5. Severe edema, dermatologic or lower extremity condition that would increase risk of skin biopsy.

6. A serious medical condition that might shorten life span or prevent exercise.

7. Subjects with obesity or hypertension considered in a dangerous range (BMI> 45, systolic BP >170, or diastolic BP >110) and those who fail a medically supervised graded maximal stress test will be excluded from the study for safety reasons.

8. An inability to understand or cooperate with the procedures of the study

9. Females who are pregnant at screening or actively plan to become pregnant during the study period, because of the marked changes in metabolism anticipated during pregnancy.

10. If ,in the investigators assessment, that participation in the study would be limited by a person's weight, size, or other physical condition.

Ishod

Primarne mjere ishoda

1. Change in Intraepidermal Nerve Fiber Density (IENFD) [Baseline, 9 months, and 18 months]

2. Change in Quality of Life (NQOL-DN) Questionnaire Results [Baseline, 9 months, and 18 months]

Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge